We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
-14.25%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$438B
AUM Growth
-$78.4B
Cap. Flow
+$5.92B
Cap. Flow %
1.35%
Top 10 Hldgs %
19.19%
Holding
4,820
New
167
Increased
1,786
Reduced
2,376
Closed
241

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$305M
2
TSLA icon
Tesla
TSLA
+$304M
3
XOM icon
ExxonMobil
XOM
+$277M
4
WBD icon
Warner Bros
WBD
+$263M
5
LIN icon
Linde
LIN
+$237M

Sector Composition

Rank Sector Weight
1 Technology 23.18%
2 Healthcare 14.61%
3 Financials 11.99%
4 Consumer Discretionary 9.25%
5 Industrials 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLDB icon
4276
Solid Biosciences
SLDB
$974M
$28K ﹤0.01%
3,057
-9,836
-76% -$102K
SND icon
4277
Smart Sand
SND
$213M
$28K ﹤0.01%
13,773
WORX
4278
DELISTED
SCWORX CORP NEW
WORX
$28K ﹤0.01%
188
-2
-1% -$382
WTER
4279
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$28K ﹤0.01%
4,700
-17
-0.4% -$147
EVLO
4280
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$28K ﹤0.01%
658
-3,894
-86% -$181K
ARTL icon
4281
Artelo Biosciences
ARTL
$2.64M
$27K ﹤0.01%
319
-2
-0.6% -$197
CURI icon
4282
CuriosityStream
CURI
$237M
$27K ﹤0.01%
16,236
-68,276
-81% -$138K
MLSS icon
4283
Milestone Scientific
MLSS
$48.9M
$27K ﹤0.01%
29,138
-1,816
-6% -$1.85K
AKBA icon
4284
Akebia Therapeutics
AKBA
$241M
$26K ﹤0.01%
71,836
-567,047
-89% -$238K
APLD icon
4285
Applied Digital
APLD
$8.81B
$26K ﹤0.01%
+25,005
New +$74.9K
BOLT icon
4286
Bolt Biotherapeutics
BOLT
$6.17M
$26K ﹤0.01%
643
-3,922
-86% -$152K
CNVS icon
4287
Cineverse
CNVS
$68.2M
$26K ﹤0.01%
2,675
ERNA icon
4288
Eterna Therapeutics
ERNA
$5.02M
$26K ﹤0.01%
7
-9
-56% -$64.6K
KRMD icon
4289
KORU Medical Systems
KRMD
$154M
$26K ﹤0.01%
10,356
LFT
4290
Lument Finance Trust
LFT
$36.4M
$26K ﹤0.01%
11,013
+271
+3% +$698
PAYS icon
4291
Paysign
PAYS
$735M
$26K ﹤0.01%
17,054
SNCR
4292
DELISTED
Synchronoss Technologies
SNCR
$26K ﹤0.01%
2,478
TYME
4293
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$26K ﹤0.01%
91,099
-415
-0.5% -$120
AQMS icon
4294
Aqua Metals
AQMS
$10.1M
$25K ﹤0.01%
153
SYRS
4295
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$25K ﹤0.01%
2,645
-16,387
-86% -$153K
AVTX icon
4296
Avalo Therapeutics
AVTX
$1.04B
$24K ﹤0.01%
17
-39
-70% -$52.2K
CATX icon
4297
Perspective Therapeutics
CATX
$354M
$24K ﹤0.01%
7,723
GNPX icon
4298
Genprex
GNPX
$2.46M
0
KPLT icon
4299
Katapult Holdings
KPLT
$35.9M
$24K ﹤0.01%
902
KRRO icon
4300
Korro Bio
KRRO
$196M
$24K ﹤0.01%
319
-1,993
-86% -$135K

Similar funds

Bank of New York Mellon's Q2 2022 Portfolio in Review

As of Q2 2022, Bank of New York Mellon held 4,820 positions worth $438B, down 15% from $516B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2022 filing shows 167 new, 1,786 increased, 2,376 reduced and 241 closed positions. Its largest new stake was Hess Midstream: 1,736,004 shares worth $48.6M. The largest sale was Apple, an estimated $403M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2022 buy was Hess Midstream: 1,736,004 shares worth $48.6M.
  • Bank of New York Mellon added most to Goldman Sachs in Q2 2022, an estimated $305M increase.
  • Bank of New York Mellon's biggest Q2 2022 reduction was Apple, cutting an estimated $403M.
  • Bank of New York Mellon fully exited Cerner Corp in Q2 2022, selling an estimated $371M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $438B portfolio in Q2 2022.
  • Bank of New York Mellon opened 167 new positions and closed 241 in Q2 2022.
  • Bank of New York Mellon's portfolio value fell 15% quarter-over-quarter to $438B.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.